Therefore, we compared some proteins of the RibGs model including NLE1, PNPT1 and PRMT1 between normal and DLBCL patients' nodes, which exhibited higher level of these proteins in patients than healthy donors (Figure 12A-C), for each protein choosing the same antibody between health and patients from the HPA database. This evidence concerns the gene PRMT1 and diffuse large B-cell lymphoma.